Lv4
560 积分 2024-04-13 加入
Changes in circulating tumor cells (CTCs) and HER2 expression in evaluating the efficacy of neoadjuvant disitamab vedotin plus toripalimab treatment in patients with muscle-invasive bladder cancer (MIBC)
5天前
已完结
Neoadjuvant Chemotherapy with Transurethral Resection for Bladder Preservation: 15-year follow-up of the retained bladder
2个月前
已关闭
皖公网安备34019202002308
